Gujarat Terce Laboratories has scheduled its 41st Annual General Meeting (AGM) for Friday, August 21, 2026. The decision was taken by the Board of Directors during a meeting held on May 29, 2026. The company has established a cut-off date to determine shareholder eligibility for e-voting and participation in the meeting.

The cut-off date for determining eligibility has been fixed as August 14, 2026. Members whose names appear in the register of members on this date will be entitled to participate in the AGM and cast their votes through the e-voting facility. The intimation was submitted to BSE Limited pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The disclosure was formally communicated by Ashka Solanki, Company Secretary of Gujarat Terce Laboratories Limited. The filing confirms that the regulatory procedural requirements for intimating the stock exchange regarding the AGM schedule have been complied with.

gujarat terce laboratories has approved the re-appointment of Mr. Aalap Prajapati as Managing Director & Chief Executive Officer for a period of five years. The decision was taken by the Board of Directors at its meeting held on 29 May 2026, based on the recommendations of the Nomination and Remuneration Committee. The re-appointment is subject to the approval of shareholders at the ensuing 41st Annual General Meeting of the Company.

Mr. Aalap Prajapati (DIN: 08088327) is liable to retire by rotation and will serve as Managing Director & CEO with effect from 28 October 2026 to 27 October 2031. He brings over 15 years of experience in the pharmaceutical and healthcare industry, with expertise in business strategy, operations management, marketing, and business development. He holds a management qualification from B.K. School of Business Management with specialization in Marketing and Operations.

The disclosure regarding the re-appointment was made pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, the details comply with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13 July 2023.

Mr. Prajapati is the son of Mr. Natwarbhai Prajapati, the Whole-Time Director of the Company. The Board confirmed that Mr. Aalap Prajapati is not debarred from holding the office of director by virtue of any SEBI order or any other such authority, as per disclosures required under BSE and NSE circulars dated 20 June 2018.

Key Details of Re-appointment